Skip to main content
Clinical Trials/NCT04181853
NCT04181853
Completed
Not Applicable

The Effect of Aerobic Exercise on Genetic Molecules Related With Metabolism

Pamukkale University1 site in 1 country70 target enrollmentFebruary 5, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes Mellitus, Type 2
Sponsor
Pamukkale University
Enrollment
70
Locations
1
Primary Endpoint
genetic molecules
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The aim of this study is to compare the effects of high intensity interval exercise and moderate intensity continuous exercise on some genetic molecules in patients with type 2 diabetes mellitus.

Detailed Description

Volunteers with type 2 diabetes mellitus will be evaluated in terms of any contra-indication that will restrain them from making exercise. 90 male or female volunteers who are suitable in terms of inclusion/exclusion criteria will be invited for the study. Volunteers will be randomly distributed to one of the 3 groups. Each group will contain 30 participants. 1. group will make aerobic exercise which is in the form of high intensity interval exercise 2.group will make aerobic exercise which is in the form of moderate intensity continuous exercise 3. Control group. Exercise groups will be cycling under observation in the hospital setting. Control group will make simple stretching exercises at home. Participants will be requested to complete a 3 months of exercise. They will be evaluated before and at the end of the 3 months of exercise with blood tests to measure genetic molecules related with metabolism.

Registry
clinicaltrials.gov
Start Date
February 5, 2020
End Date
May 30, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

GULIN FINDIKOGLU

Associate Professor

Pamukkale University

Eligibility Criteria

Inclusion Criteria

  • Clinica diagnosis of type 2 Diabetes mellitus less than 10 years and more than 1 year.
  • must have appropriate medical therapy and diet.
  • must not be treated with insulin.
  • must be exercising less than 210 minutes/ week

Exclusion Criteria

  • prominent cardiovascular disease
  • coronary artery disease
  • moderate to severe valvular disease
  • atrial fibrillation
  • untreated hypertension
  • congenital heart disease
  • retinopathy
  • neuropathy
  • macro albuminuria
  • cerebrovascular disease

Outcomes

Primary Outcomes

genetic molecules

Time Frame: 12 weeks

HbA1c level in the serum

Study Sites (1)

Loading locations...

Similar Trials